Y Liu, B Hu, C Fu, X Chen - Bioinformatics, 2010 - academic.oup.com
Rapid advances in pharmaceutical sciences have brought ever-increasing interests in combined therapies for better clinical efficacy and safety, especially in cases of complicated …
Highlights•Currently a vast heterogeneity in synergistic drug action scoring and analysis exists.•Novel cellular models offer robust ways to identify relevant combination …
L Xie, X Ge, H Tan, L Xie, Y Zhang, T Hart… - PLoS computational …, 2014 - journals.plos.org
Genome-Wide Association Studies (GWAS), whole genome sequencing, and high- throughput omics techniques have generated vast amounts of genotypic and molecular …
Introduction: Polypharmacology has emerged as an essential paradigm for modern drug discovery process. Multiple lines of evidence suggest that agents capable of modulating …
JC Nacher, JM Schwartz - PloS one, 2012 - journals.plos.org
Recent studies have highlighted the importance of interconnectivity in a large range of molecular and human disease-related systems. Network medicine has emerged as a new …
L Huang, D Brunell, C Stephan, J Mancuso, X Yu… - …, 2019 - academic.oup.com
Motivation Drug combinations that simultaneously suppress multiple cancer driver signaling pathways increase therapeutic options and may reduce drug resistance. We have …
D Chen, H Zhang, P Lu, X Liu, H Cao - Molecular BioSystems, 2016 - pubs.rsc.org
Drug combinations have been widely applied to treat complex diseases, like cancer, HIV and cardiovascular diseases. One of the most important characteristics for drug …
The pharmaceutical industry faces unprecedented pressures based largely on the inability to bring sufficient new medicines to market. The high failure rate of drug candidates in …
SM Stefan, M Rafehi - Drug Development Research, 2024 - Wiley Online Library
At the core of complex and multifactorial human diseases, such as cancer, metabolic syndrome, or neurodegeneration, are multiple players that cross‐talk in robust biological …